# Opioid Prescription After Cesarean Trial

> **NCT04296396** · PHASE3 · COMPLETED · sponsor: **The George Washington University Biostatistics Center** · enrollment: 5521 (actual)

## Conditions studied

- Pregnancy Related
- Opioid Use
- Pain

## Interventions

- **DRUG:** 0 to 20 tablets of oxycodone 5mg
- **DRUG:** Fixed opioid prescription

## Key facts

- **NCT ID:** NCT04296396
- **Lead sponsor:** The George Washington University Biostatistics Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-21
- **Primary completion:** 2022-04-07
- **Final completion:** 2022-07-08
- **Target enrollment:** 5521 (ACTUAL)
- **Last updated:** 2023-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04296396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04296396, "Opioid Prescription After Cesarean Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04296396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*